Abstract:BACKGROUND:Cyclo-oxgenase 2 (COX-2) is involved in prostaglandin synthesis in central nervous system, and it also plays a role in human carcinogenesis. Our purpose of this study is to investigate the COX-2 expression in different development stages of colorectal cancer, and to discuss the relationship between the gene expression and clinicopathological features of the cancer.METHODS:COX-2 expression was examined by immunohistochemical staining in 76 surgical specimens of colorectal cancer (44 of advanced stage and 32 of early stage), thirty-three adenomas and 18 normal colonic mucosal tissues taken by endoscopic biopsy. Kaplan-Meier survival curves and Cox proportional hazards regression were used to evaluate the relation of COX-2 to prognosis.RESULTS:COX-2 expression, divided into 4 grades from "-" to "+++", is respectively 83.3%, 16.7%, 0% and 0% in normal colonic mucosal tissues; 12.1%, 42.4%, 36.4% and 9.1% in adenomas; 6.3%, 28.1%, 46.9% and 18.7% in early colorectal cancers (ECCs), and 6.8%, 20.5%, 18.2% and 54.5% in advanced colorectal cancers (CRCs). The differences in COX-2 expression between advanced CRCs and early colorectal cancers (ECCs) as well as between the advanced CRCs and adenomas were statistically significant (P < 0.01); but there was no significant difference between ECCs and adenomas. Kaplan-Meier survival analysis showed a significant difference in the survival curves between low high COX-2 groups (P < 0.05). Cox proportional hazards regression showed that COX-2 expression was related to poorer long-term outcome with a hazard ratio of 2.665 unadjusted for other variables (P < 0.05), and COX-2 expression was an independent risk factor of poor prognosis.CONCLUSIONS:COX-2 expression is gradually up-regulated in the development from normal epithelium to adenomas and from ECCs to advanced CRCs. Alhough the COX-2 protein can not be regarded as a tumor marker to diagnose CRCs early, COX-2 expression can be regarded as an independent risk factor of poor prognosis for postoperative patients with advanced CRCs.

EXPRESSION AND POSSIBLE ROLE OF CYCLOOXYGENASE-2 IN ORAL SQUAMOUS CELL CARCINOMA

Expression of cyclooxygenase 2 in colorectal cancer

Cyclooxygenase-2 Expression and Its Correlation with Vascular Endothelial Growth Factor in Oral Squamous Cell Carcinoma

EXPRESSION OF CYCLOOXYGENASE-2 (COX-2) IN HUMAN TONGUE SQUAMOUS CELL CARCINOMA AND ITS PRECANCEROUS LESIONS

Relationship Between Expression of COX-2 and Clinicopathological Characteristics in Human Gastric Cancer

Expression of the cyclooxygenase-2 gene and its clinical significance in non-small cell lung cancer

COX-2, MMP-7 Expression in Oral Lichen Planus and Oral Squamous Cell Carcinoma

Expression and Clinical Significance of Cyclooxygenase-2 in Tumor of Laryngeal Squamous Cell Carcinoma

A study on cyclooxygenase-2 protein expression in tongue carcinoma and precancerous lesions

Cyclooxygenase-2 expression correlates with angiogenesis and vascular endothelial growth factor-A in non-small cell lung cancer

[Expression of Cyclooxygenase-2 in Esophageal Squamous Cell Carcinogenesis].

COX-2 Expression and Angiogenesis in Oral Squamous Cell Carcinom

[Expression of Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in Tongue Hyperplasia and Tongue Squamous Cell Carcinoma].

Significance of Cox-2 Expression in Human Esophageal Squamous Cell Carcinoma

Detection of COX-2 in Squamous Cell Carcinoma

Cyclooxygenase-2 expression in squamous dysplasia and squamous cell carcinoma of the esophagus.

Relationship Between COX-2 Expression and Clinicopathological Features of Colorectal Cancers

Study on the role of cyclooxygenase-2 in carcinogenesis of oral submucous fibrosis

Expression of Cyclooxygenase -2 in Skin Carcinoma and Its Clinical Significance

The Prognostic Roles of Cyclooxygenase-2 for Patients with Basal Cell Carcinoma.

Relationship between COX-2 and cell cycle-regulatory proteins in patients with esophageal squamous cell carcinoma.